Public Law 118-107 – Congenital Heart Futures Reauthorization Act of 2024
Summary
The Congenital Heart Futures Reauthorization Act of 2024 (Public Law 118-107) was enacted on November 27, 2024. This law reauthorizes and expands the Congenital Heart Futures Reauthorization Act of 2018 (Public Law 115-292).
Purpose
The purpose of the Congenital Heart Futures Reauthorization Act of 2024 is to improve the health outcomes of individuals with congenital heart disease (CHD), which is the most common birth defect in the United States. The law aims to do this by supporting research, education, and surveillance efforts related to CHD.
Key Provisions
The Congenital Heart Futures Reauthorization Act of 2024 includes several key provisions, including:
- Research Funding: The law authorizes $75 million annually in funding for research on congenital heart disease. This funding will support research on the causes, prevention, diagnosis, and treatment of CHD.
- Education and Training: The law provides funding for training programs for healthcare professionals who treat individuals with CHD. This training will help to improve the quality of care for individuals with CHD.
- Surveillance: The law requires the Centers for Disease Control and Prevention (CDC) to collect and analyze data on the prevalence, incidence, and mortality of congenital heart disease. This data will help to identify trends in CHD and track progress in improving health outcomes.
- National Congenital Heart Disease Registry: The law establishes a national congenital heart disease registry. This registry will collect data on individuals with CHD throughout their lifetimes. The data will be used to improve understanding of CHD and develop better treatments and interventions.
Impact
The Congenital Heart Futures Reauthorization Act of 2024 is expected to have a significant impact on the lives of individuals with congenital heart disease. The law will provide much-needed funding for research, education, and surveillance efforts related to CHD. This will lead to improvements in the quality of care for individuals with CHD and ultimately help to improve their health outcomes.
Additional Information
For more information on the Congenital Heart Futures Reauthorization Act of 2024, please visit the following websites:
Public Law 118 – 107 – Congenital Heart Futures Reauthorization Act of 2024
The AI has provided us with the news.
I’ve asked Google Gemini the following question, and here’s its response.
Public and Private Laws a new article on 2024-11-27 14:56 titled “Public Law 118 – 107 – Congenital Heart Futures Reauthorization Act of 2024”. Please write a detailed article on this news item, including any relevant information. Answers should be in English.
38